Document Classification

Section Type: RESULTS

Text: In the pioglitazone group, compared with glimepiride, high-density lipoprotein levels increased 5. 7 mg/dL (95 % CI, 4. 4 to 7. 0 mg/dL ; 16. 0 %) vs 0. 9 mg/dL (95 % CI, -0. 3 to 2. 1 mg/dL ; 4. 1 %), and median triglyceride levels decreased 16. 3 mg/dL (95 % CI, -27. 7 to -11. 0 mg/dL ; 15. 3 %) vs an increase of 3. 3 mg/dL (95 % CI, -10. 7 to 11. 7 mg/dL ; 0. 6 %) (P <. 001 for both comparisons).